Migraine (Pediatric) Clinical Trials

A listing of Migraine (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 102 clinical trials
featured
Migraine (Pediatric)

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years. Eligibility Criteria: Each child must have a responsible trained adult with knowledge of the conduct of the study and must be available to supervise migraine …

headache
nasal spray
acute treatment
acute migraine
  • 212 views
  • 23 Nov, 2020
  • 1 location
featured
994/995_Migraine Headache Research Study for Children & Adolescents

This study is testing an investigational migraine medication for children and adolescents

  • 49 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents.

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents.  

  • 316 views
  • 07 Nov, 2020
  • 1 location
featured
Pediatric Migraine Research Study

It's estimated that upwards of 28% of adolescents will experience migraines. Because of this, migraines are ranked as one of the top five health issues affecting children. If your child struggles with migraine symptoms, they may be eligible for a research study evaluating a study medication. This study is being …

  • 57 views
  • 23 Nov, 2020
  • 1 location
featured
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1

This study will help us learn more about a medicine called lasmiditan. We are testing this medicine to find out if it helps children who have migraine attacks. 

migraines
migraine
migraine in children
acute migraine
  • 0 views
  • 28 Jan, 2021
  • 1 location
featured
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study

This study will help us learn more about a study drug called galcanezumab. We are testing this study drug to find out if it is safe and effective at helping adolescents who have chronic migraine headaches.

chronic migraine
migraine in children
migraine
  • 0 views
  • 27 Jan, 2021
  • 1 location
featured
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age with Episodic Migraine – the REBUILD-1 Study

This study will help us learn more about a study drug called galcanezumab. We are testing this study drug to find out if it is safe and effective at helping children and adolescents who have episodic migraine.

episodic migraine
migraines
migraine in children
migraine
  • 0 views
  • 27 Jan, 2021
  • 1 location
featured
Does your child experience migraine headaches?

Does your child experience migraine headaches?

  • 208 views
  • 08 Nov, 2020
  • 1 location
Effect of Acupressure in Migraine: Single-blinded Randomized Controlled Clinical Trial

Background : Migraine is one of the most complex, prevalent, debilitating neurologic disorder in the world. In clinical experience, there are limitation over western medicine for migraine, especially some extra adverse effects. In traditional Chinese medicine(TCM), there are some reviews and clinical practice point out acupressure at PC6 could relieve …

calcitonin gene-related peptide
nausea
calcitonin
  • 0 views
  • 14 Jul, 2021
  • 1 location
Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with episodic migraine. The study hypothesis is that in pediatric subjects with episodic migraine, the combined erenumab dose group has a greater reduction from baseline …

episodic migraine
headache
erenumab
  • 226 views
  • 08 Jul, 2021
  • 178 locations